Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1352720

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1352720

Contract Research Outsourcing

PUBLISHED:
PAGES: 453 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5800
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17400

Add to Cart

Description

Table of Contents

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Contract Research Outsourcing Market to Reach $90.4 Billion by 2030

The global market for Contract Research Outsourcing estimated at US$49.8 Billion in the year 2022, is projected to reach a revised size of US$90.4 Billion by 2030, growing at a CAGR of 7.7% over the period 2022-2030. Clinical, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$61.2 Billion by the end of the analysis period. Growth in the Discovery segment is estimated at 6.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $20.1 Billion, While China is Forecast to Grow at 10.1% CAGR

The Contract Research Outsourcing market in the U.S. is estimated at US$20.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Select Competitors (Total 152 Featured) -

  • Charles River Laboratories International, Inc.
  • Galapagos NV
  • Albany Molecular Research, Inc.
  • Axxam SpA
  • Cyprotex Limited
  • BioClinica
  • HD Biosciences Co., Ltd.
  • Clinipace Inc.
  • CMIC Holdings Co., Ltd.
  • EAG Laboratories
  • Envigo, Inc.
  • Genoway S.A.
  • EPS International Co., Ltd.
  • GenScript Biotech Corporation
  • Absorption Systems LLC
Show more
Product Code: MCP-1534

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry
    • Players Focus on Collaborative Approach
    • Optimism Reigns in Latter Part of 2020
    • COVID-19 and Implications for Drug Development Regulations & Processes
    • Opportunities in COVID-19 Programs
    • Parallel Gains for Development & Manufacturing
    • Contract Research Outsourcing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Contract Research Outsourcing: An Introduction
    • Key Service Markets
    • Market Dynamics
    • Key Therapeutic Areas of Clinical Trial Research
    • Global Clinical Trial Services Market by Therapeutic Area: 2019
    • Top 6 Therapeutic Categories by Number of R&D Products in 2020
    • Cost Savings Hold Relevance
    • Product Innovations & Enhanced Speed
    • Access to Expertise & Sophisticated Technology
    • Outlook
    • Regional Market Analysis
    • Future Model of CRO
  • COMPETITIVE SCENARIO
    • CRO: A Highly Fragmented Market
    • Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player
    • Partnership Models Pay Returns
    • Strategies and Tactical Programs
    • Large CROs Seek the Inorganic Growth Route
    • Key Opportunities for CROs
    • Technological Superiority: An Advantage
    • Consolidation to Gain Pace
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Uptrend in Advanced Medicine Concepts Favors Growth
    • Drug Developers Bet on CROs to Sail through Challenging Aspects
    • Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
    • Gene Therapy Offers Exciting Opportunities for CROs
    • COVID-19 Creates a Pause in Gene Therapy Market Growth
    • Gene Therapy Set to Witness Rapid Growth Post COVID-19
    • Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
    • Increasing Significance of Biologic Drugs Supports Market Demand
    • Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
    • COVID-19 Drives Strong Gains for Biologics Activity
    • Opportunities Rife in Early Stage Drug Development
    • Notable Trends in Pharma/Biopharma R&D Impacting CROs
    • Advances in Digital/Technology and its Impact on Clinical Development
    • Significant Strides Taken in the Sphere of Current Clinical Research
    • Data Quality Oversight (DQO) Undergoes Change
    • Pharmacovigilance Set to Grow
    • Artificial Intelligence and Machine Learning Gain Interest
    • Orphan Drugs to the Fore
    • CROs Adapt New Technologies to See More Business in Future
    • Streamlining Development of Novel Trial Designs
    • Industry Witnesses Increased Spend on R&D Outsourcing
    • Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
    • Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019
    • Focus on Enhancing Site Selection and Patient Enrollment
    • CROs Enter into Alliances to Improve Efficiencies
    • Adoption of Digital Technologies Gains Pace
    • Toxicology Services Gain Notable Attention
    • Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
    • Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
    • Global Biopharma % R&D Outsourcing (2014-2022)
    • New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
    • eClinical Solutions Gain Traction
    • Other Noteworthy Market Trends
    • Challenges Faced by Contract Research Organizations
    • Surging Global Population Offers Increased Growth Opportunities
    • World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
    • Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Contract Research Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Market Overview
    • COVID-19 Pandemic: Mixed Bag of Opportunities for CROs
    • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
    • Trial Services Witness Strong Demand
    • High Demand for Data Management Services
    • Risk-based Monitoring Catches Pace
    • Market Analytics
    • TABLE 26: USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • JAPAN
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • CHINA
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Market Overview
    • TABLE 44: China Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • EUROPE
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • Market Overview
    • Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments
    • Providers Expand Services in Downstream Drug Development
    • Market Analytics
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • FRANCE
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • GERMANY
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Market Overview
    • Asia-Pacific to Push Up Volume Share in CRO Market
    • R&D Outsourcing in Life Sciences on Rise
    • Market Analytics
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • INDIA
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • Indian CROs Seek Opportunities
    • TABLE 110: India Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: India 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: India 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • Market Overview
    • Australia: Popular Destination for Early Phase Clinical Trials
    • Market Analytics
    • TABLE 116: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Rest of Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 122: Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Latin America 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of World 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!